Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs
· thenextweb.com · popularity 21/100 · 0 similar stories today · Public Health & Epidemiology (Health & Life Sciences)
Read the original at thenextweb.com →
Summary
Scottish biotech PhaSER Biomedical has won a $2.7M (£2m) grant from the Gates Foundation to help find new drugs for diseases such as TB and malaria. The company announced the award in a statement this morning. The two-year grant renews PhaSER’s place in the foundation’s Global Health Discovery Collaboratory, a programme that gives Gates-funded teams access […] This story continues at The Next Web
Found in: The Next Web. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.